Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/2008
10/08/2008EP1379246B1 Nociceptin analogs
10/08/2008EP1320589B1 Antiangiogenic polypeptides and methods for inhibiting angiogenesis
10/08/2008EP1283042B1 Aqueous liquid preparation of pranoprofen
10/08/2008CN101282974A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101282761A Benzimidazole derivatives as SIRTUIN modulators
10/08/2008CN101279966A Optical isomer of Nipradilol, preparation and medical use thereof
10/08/2008CN101279046A Chinese medicinal composition for curing labyrinthine syndrome
10/08/2008CN101279027A Chinese medicine lotion preparation for curing acute conjunctivitis
10/08/2008CN101279008A Chinese medicine pad pasting for preventing and controlling myopic eye, eyestrain symptoms and eyebase ischemia
10/08/2008CN101278992A Shanbei eye drop
10/08/2008CN101278937A Clear eye lotion containing latanoprost as effective ingredient
10/08/2008CN101278936A Clear eye lotion containing latanoprost as effective ingredient
10/08/2008CN101278925A Application of embellin in preparation of medicament for inhibiting angiogenesis
10/08/2008CN101278908A Eye drop capable of significantly increasing medicament effect
10/08/2008CN101278905A Ophthalmic composition containing natamycin, use and preparation method thereof
10/08/2008CN101278895A Instant type gel preparation for eye and method of producing the same
10/08/2008CN100423731C Eye brightening eye washing liquid and its preparation method
10/07/2008US7432366 Moraxella catarrhalis BASB034 polypeptides and used thereof
10/07/2008US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors
10/07/2008US7432286 Pharmaceutically active sulfonyl hydrazide derivatives
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432254 Method for treating glaucoma IC
10/07/2008US7432252 Method of promoting cervical and vaginal secretions
10/07/2008CA2435946C Piperidine derivatives as neurokinin 1 antagonists
10/07/2008CA2427573C Indole derivatives as pde5-inhibitors
10/07/2008CA2411544C N-alkyl-adamantyl triazinyl benzamide derivatives
10/07/2008CA2331461C Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
10/07/2008CA2181909C Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
10/02/2008WO2008117862A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
10/02/2008WO2008117861A1 Intraocular pressure lowering agents containing phenylenediamine derivatives as the active ingredient
10/02/2008WO2008117815A1 Inhibitor for cell death caused by endoplasmic reticulum stress or oxidation stress
10/02/2008WO2008117767A1 Therapeutic agent for infectious skin or mucosal disease
10/02/2008WO2008117389A1 Drug for treating retinal disorders, utilization of the same and therapeutic method using the same
10/02/2008WO2008116806A1 Use of a masked or coated copper salt for the treatment of macular degeneration
10/02/2008WO2008094825A3 Compositions and methods for maintaining, strengthening, improving or promoting eye health
10/02/2008WO2008082948A3 Ophthalmic alginate composition related methods of manufacture and methods of use
10/02/2008WO2008073752A3 Cyclobutyl derivatives for the treatment of glaucoma
10/02/2008WO2008057867A3 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier
10/02/2008WO2008033655A3 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
10/02/2008US20080242741 Intranasal drug delivery system
10/02/2008US20080242724 ointment or eyedrops; addition of maleic acid, dissolved in a suitable organic solvent, to ibopamine base
10/02/2008US20080242703 Pharmaceutical compositions for the treatment of hearing loss
10/02/2008US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
10/02/2008US20080242669 compounds which mimic the secondary structure of alpha -helix regions of biologically active peptides and proteins; compounds are used to reverse fibrotic conditions
10/02/2008US20080242652 Indole derivatives and their metal conjugates and uses thereof
10/02/2008US20080242619 Peptidomimetics ; determine ability to bind to growth hormone secretagogue; ghrelin antagonist; appetite stimulation; dietetics ; weight maintenance; eating disorders
10/02/2008US20080242591 Treating vascular malformation with nicotinic acetylcholine receptor (nAChR) antagonist; arthritis, cancer
10/02/2008US20080241960 Insulin-like growth factor binding protein specific monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, muscular and vision disorders
10/02/2008US20080241835 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
10/02/2008US20080241224 Non-Polymeric Lipophilic Pharmaceutical Implant Compositions For Intraocular Use
10/02/2008US20080241223 Implanting the extended release, biodegradable implant containing dexamethasone directly into the vitreous of the eye; side effect reduction; macular degeneration; angiogenesis inhibition
10/02/2008US20080241219 Implanting the extended release, biodegradable implant containing dexamethasone directly into the vitreous of the eye; side effect reduction; macular degeneration
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080237028 Nucleation in liquid, methods of use thereof and methods of generation thereof
10/02/2008CA2681514A1 Use of a masked or coated copper salt for the treatment of macular degeneration
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/01/2008EP1975164A2 Octahydrobenzimidazolone compounds as analgetics
10/01/2008EP1974738A2 Diagnostics and therapeutics for glaucoma
10/01/2008EP1974733A1 Use of a masked or coated copper salt for the treatment of macular degeneration
10/01/2008EP1973535A2 Method for the treatment of tinnitus
10/01/2008EP1879570A4 Inhibition of reactive oxygen species and protection of mammalian cells
10/01/2008EP1585523B1 Use of purine derivatives for inducing differentiation of supernumerary hair cells and deiters' cells in the developing organ of corti for treating deafness
10/01/2008EP1331935B1 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them
10/01/2008EP1251862B1 Ophthalmic compositions for treating ocular hypertension
10/01/2008EP1212295B1 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
10/01/2008CN101277965A N-phenyl benzamide derivatives as sirtuin modulators
10/01/2008CN101277963A Benzimidazole derivatives as SIRTUIN modulators
10/01/2008CN101274056A Compound formulation of tablets for eliminating hypometropia and producing process
10/01/2008CN101273994A Pharmaceutical composition for curing diabetic retina pathological changes and method of preparing the same
10/01/2008CN100422164C Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
10/01/2008CN100422161C Hydroxymorpholinone derivative and medicinal use thereof
10/01/2008CN100421726C Nano compound eye-drop containing piptide-like medicine and preparing method
09/2008
09/30/2008US7429663 7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3β inhibitors
09/30/2008US7429615 Cyclohexyl prostaglandin analogs as EP4-receptor agonists
09/30/2008US7429602 Treating conjunctivitis by topically administering an epinastine solution to the conjunctiva
09/30/2008US7429592 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008US7429574 4-heterocyclo-pyrrolo[2,3d] pyrimidine compositions and their use
09/30/2008US7429488 Method for processing lipoaspirate cells
09/30/2008US7429483 Use of nerve growth factor for the storage, culture or treatment of cornea
09/25/2008WO2008114819A1 Novel adenine compound
09/25/2008WO2008114817A1 Novel adenine compound
09/25/2008WO2008114114A2 Poly(adp-ribose) polymerases inhibitor for treating ophthalmic condition
09/25/2008WO2008113863A2 Nitrosated derivatives of 2,5-dihydroxybenzene compounds
09/25/2008US20080234351 Treating diabetic retinopathy, particularly moderately to very severe non-proliferative diabetic retinopathy, by administering ruboxistaurin or a salt such as mesylate conjunction with focal or grid laser photocoagulation
09/25/2008US20080234346 Pyrazalidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
09/25/2008US20080234309 Macrocyclic lactone compounds and methods for their use
09/25/2008US20080234266 Squaric Acid Derivatives II
09/25/2008US20080234247 Heterocyclic analgesic compounds and methods of use thereof
09/25/2008US20080234245 Angiostatic Agents for Controlling Choroidal Neovascularisation After Ocular Surgery or Trauma
09/25/2008US20080233182 Organic compounds
09/25/2008US20080233173 Inserting an implant into an ocular site; an active agent and a polymer carrier; releasing the active agent from the implant
09/25/2008US20080233171 Inserting an implant into an ocular site; an active agent and a polymer carrier; releasing the active agent from the implant
09/25/2008US20080233154 Immunoprotective and nontoxic Gram-negative bleb vaccine suitable for paediatric use; Neisseria meningitides; H. influenzae
09/25/2008CA2680397A1 Novel adenine compound
09/24/2008EP1972340A2 Method of preparing an aqueous meloxicam solution and the resulting aqueous solution
09/24/2008EP1971288A2 Micronized device for the delivery of biologically active molecules and methods of use thereof
09/24/2008EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
09/24/2008EP1513520B1 Substituted pyrrolines as kinase inhibitors
09/24/2008EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 531